Rotavirus Vaccine Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Rotavirus Vaccine Market
1.1. Definition and Scope
1.1.1. Definition of Rotavirus Vaccine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Rotavirus Vaccine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Rotavirus Vaccine Market By Type
1.2.3. Rotavirus Vaccine Market By End-Use
1.2.4. Rotavirus Vaccine Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Rotavirus Vaccine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Rotavirus Vaccine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Cost Structure Analysis
3.9.1. Price Trend of Key Raw Materials
3.9.2. Raw Material Suppliers
3.9.3. Proportion of Manufacturing Cost Structure
3.9.3.1. Raw Material Cost
3.9.3.2. Labor Cost
3.9.3.3. Manufacturing Expense
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Rotavirus Vaccine Market Revenue By Type
5.1. Introduction
5.2. Rotavirus Vaccine Market Revenue (USD Million) By Type
5.2.1. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
5.2.2. Lanzhou Lamb
5.2.2.1. Lanzhou Lamb Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Rotarix
5.2.3.1. Rotarix Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Rotavac
5.2.4.1. Rotavac Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Rotavin-M1
5.2.5.1. Rotavin-M1 Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Others
5.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Rotavirus Vaccine Market Revenue By End-Use
6.1. Introduction
6.2. Rotavirus Vaccine Market Revenue (USD Million) By End-Use
6.2.1. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Clinics
6.2.3.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Academic & Research Lab
6.2.4.1. Academic & Research Lab Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Rotavirus Vaccine Market By Country
7.1. North America Rotavirus Vaccine Market Overview
7.2. U.S.
7.2.1. U.S. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
7.2.2. U.S. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
7.3.2. Canada Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Rotavirus Vaccine Market By Country
8.1. Europe Rotavirus Vaccine Market Overview
8.2. U.K.
8.2.1. U.K. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
8.2.2. U.K. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
8.3.2. Germany Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
8.4.2. France Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
8.5.2. Spain Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
8.6.2. Rest of Europe Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia-Pacific Rotavirus Vaccine Market By Country
9.1. Asia-Pacific Rotavirus Vaccine Market Overview
9.2. China
9.2.1. China Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.2.2. China Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.3.2. Japan Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.4.2. India Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.5.2. Australia Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.6. South Korea
9.6.1. South Korea Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.6.2. South Korea Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
9.7.2. Rest of Asia-Pacific Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Rotavirus Vaccine Market By Country
10.1. Latin America Rotavirus Vaccine Market Overview
10.2. Brazil
10.2.1. Brazil Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
10.2.2. Brazil Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
10.3.2. Mexico Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
10.4.2. Rest of Latin America Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Rotavirus Vaccine Market By Country
11.1. Middle East & Africa Rotavirus Vaccine Market Overview
11.2. GCC
11.2.1. GCC Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
11.2.2. GCC Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
11.3.2. South Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030
11.4.2. Rest of Middle East & Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Rotavirus Vaccine Market
12.1. Rotavirus Vaccine Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of Key Players by Price, Presence, Market Share, and R&D Investment
12.2.2. Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Rotavirus Vaccine Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. BIOVIRx Inc
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Market Revenue (USD Million), 2021
13.1.3.2. BIOVIRx Inc 2021 Rotavirus Vaccine Business Regional Distribution
13.1.4. Product/service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Serum Institute of India Pvt. Ltd.
13.3. Merck & Co., Inc.
13.4. Bharat Biotech
13.5. Biological E
13.6. Bio Farma
13.7. Novartis AG
13.8. GlaxoSmithKline plc.
13.9. Sanofi
13.10. Lanzhou Institute of Biologicals Products Co., Ltd
13.11. Berghofer Medical Research Institute
13.12. Pfizer, Inc.
Frequently Asked Questions
How much was the global rotavirus vaccine market size in 2021?
The global rotavirus vaccine market size in 2021 was accounted to be USD 9,053 Million.
What will be the projected CAGR for global rotavirus vaccine market during forecast period of 2022 to 2030?
The projected CAGR of rotavirus vaccine during the analysis period of 2022 to 2030 is 11%.
Which are the prominent competitors operating in the market?
The prominent players of the global rotavirus vaccine market involve BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bharat Biotech, Biological E, Bio Farma, Novartis AG, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, Berghofer Medical Research Institute, and Pfizer, Inc.
Which region held the dominating position in the global rotavirus vaccine market?
North America held the dominating share for rotavirus vaccine during the analysis period of 2022 to 2030.
Which region exhibited the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for rotavirus vaccine during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global rotavirus vaccine market?
Rising rotavirus infection rates among infants, growth in the number of adults with compromised immune systems, and an increase in the old population are the prominent factors that fuel the growth of global rotavirus vaccine market.
By segment end-use, which sub-segment held the maximum share?
Based on end-use, hospitals segment held the maximum share for rotavirus vaccine market in 2021.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
